Subgroup analysis limited to patients without HF at baseline did not reach statistical significance towards reduced HHF in the SGLT2i user group (RR 0.43, 95% CI 0.15–1.23, P = 0.11, I 2=91%) ( Figure 4 ).
← all excerpts
Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis.
1
0.1100
0.1100